Stay updated on Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.

Latest updates to the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page
- Check5 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a new release of the study history page. The update does not change study content or navigation.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe record history now includes a line indicating recruitment is closed: 'No longer looking for participants', signaling the study is no longer enrolling participants. It also adds a new revision tag 'Revision: v3.6.0', marking an updated version of the study record and replacing the previous revision v3.5.5.SummaryDifference0.3%

- Check26 days agoChange DetectedVersion v3.5.5 has been added to the study history, superseding the previous v3.5.4. This update records a new iteration of the study record without altering its substantive content.SummaryDifference0.1%

- Check41 days agoChange DetectedNew revision adds sections for Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow, along with Document Section and Study Status. The update also notes that a Quality Control Review Has Not Concluded and shows a Returned date of 2026-05-19.SummaryDifference0.7%

- Check48 days agoChange DetectedA new revision entry v3.5.4 was added to the page's revision history, and the previous revision v3.5.3 was removed from the history.SummaryDifference0.1%

- Check70 days agoChange DetectedThe revision/version indicator for this page updated from **v3.5.2** to **v3.5.3**, reflecting a small technical release with no substantive change to the clinical trial information shown.SummaryDifference0.1%

Stay in the know with updates to Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.